Specific features of the diagnosis and treatment of community-acquired pneumonia in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The diagnosis of community-acquired pneumonia and the choice of adequate therapy during pregnancy have a number of features. This is due to both clinical features and certain restrictions on the prescription of antibacterial drugs, some groups of which may have a negative effect on a fetus.

Full Text

Restricted Access

About the authors

O. Lavrova

I.P. Pavlov First Saint Petersburg State Medical University

Email: loverova@bk.ru
Professor MD

M. Petrova

I.P. Pavlov First Saint Petersburg State Medical University

Professor MD

References

  1. Чучалин А.Г. и соавт. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике // Клин. микробиол. антимикроб. химиотер. - 2006; 8 (1): 54-86.
  2. Внебольничная пневмония. Клинические рекомендации / Российское респираторное общество, 2018. spulmo.ru
  3. Jin Y., Carriere K., Marrie T. et al. The effects of community-acquired pneumonia during pregnancy ending in a live birth // Am. J. Obstet. Gynecol. -2003; 18: 800-6.
  4. Goodnight W., Soper D. Pneumonia in pregnancy // Crit. Care Med. - 2005; 33 (10 Suppl) : 390-7.
  5. Panting-Kemp A., Geller S., Nguyen T. et al. Maternal deaths in an urban perinatal network, 1992-1998 // Am. J. Obstet. Gynecol. - 2000; 183: 1207-12.
  6. Lim W., Macfarlane J., Colthorpe C. Treatmentof community-acquired lower respiratory tract infections during pregnancy // Am. J. Respir. Med. - 2003; 2: 221-33.
  7. Mehta N., Chen K., Hardy E. et al. Pneumonia in pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. - 2015; 29 (5): 598-611.
  8. Madinger N., Greenspoon J., Ellrodt A. Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? // Am. J. Obstet. Gynecol. - 1989; 161: 657-62.
  9. Синопальников А.И., Фесенко О.В. Внебольничная пневмония / М.: ГЭОТАР-Медиа, 2017; 112 с.
  10. Tan E.K., Tan E.L. Alterations in physiology and anatomy during pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. - 2013; 27: 791-802.
  11. Brito V., Niederman M. Pneumonia complicating pregnancy // Clin. Chest Med. - 2011; 32: 121-32.
  12. Romanyuk V., Raichel L., Sergienko R. et al. Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes // J. Matern. Fetal. Neonatal. Med. - 2011; 24 (1): 113-7.
  13. Ie S., Rubio E., Alper B. et al. Respiratory complications of pregnancy // Obstet. Gynecol. Surv. - 2001; 57: 39-46.
  14. Wacker E., Navarro A., Meister R. et al. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome // Pharmacoepidemiol. Drug Saf. - 2015; 24 (4): 353-60.
  15. Berkovitch M., Diav-Citrin O., Greenberg R. et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study // Br. J. Clin. Pharmacol. - 2004; 58 (3): 298-302.
  16. Czeizel A., Rockenbauer M., Sorensen H. et al. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2001; 97 (2): 188-92.
  17. Lin K., Mitchell A., Yau W. et al. Safety of macrolides during pregnancy // Am. J. Obstet. Gynecol. - 2013; 208 (3): 221.e1-8. DOI: 10.1016/j. ajog.2012.12.023.
  18. Padberg S., Wacker E., Meister R. et al. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones // Antimicrob. Agents Chemother. - 2014; 58 (8): 4392-8. doi: 10.1128/AAC.02413-14.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies